Liquidia Corp (LQDA)
12.34
+0.38
(+3.18%)
USD |
NASDAQ |
May 15, 15:46
Liquidia Accounts Payable (Quarterly): 2.49M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.49M |
| December 31, 2023 | 1.396M |
| September 30, 2023 | 1.812M |
| June 30, 2023 | 1.918M |
| March 31, 2023 | 0.841M |
| December 31, 2022 | 2.197M |
| September 30, 2022 | 1.14M |
| June 30, 2022 | 1.412M |
| March 31, 2022 | 1.666M |
| December 31, 2021 | 1.07M |
| September 30, 2021 | 1.609M |
| June 30, 2021 | 2.547M |
| March 31, 2021 | 3.004M |
| Date | Value |
|---|---|
| December 31, 2020 | 3.734M |
| September 30, 2020 | 3.415M |
| June 30, 2020 | 2.520M |
| March 31, 2020 | 5.530M |
| December 31, 2019 | 3.498M |
| September 30, 2019 | 4.544M |
| June 30, 2019 | 4.100M |
| March 31, 2019 | 5.988M |
| December 31, 2018 | 3.236M |
| September 30, 2018 | 2.908M |
| June 30, 2018 | 3.579M |
| March 31, 2018 | 4.713M |
| December 31, 2017 | 4.425M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.841M
Minimum
Mar 2023
5.530M
Maximum
Mar 2020
2.522M
Average
2.344M
Median
Accounts Payable (Quarterly) Benchmarks
| United Therapeutics Corp | -- |
| AIM ImmunoTech Inc | 6.443M |
| Perspective Therapeutics Inc | 6.107M |
| Protalix BioTherapeutics Inc | 3.146M |
| Armata Pharmaceuticals Inc | 2.057M |